EFFECT OF L-THYROXINE THERAPY ON LIPOPROTEIN FRACTIONS IN OVERT AND SUBCLINICAL HYPOTHYROIDISM, WITH SPECIAL REFERENCE TO LIPOPROTEIN(A)

The effect of L-thyroxine therapy on lipoprotein fractions was assesse d in 15 patients with overt hypothyroidism (14 women and one man aged 45 +/- 3.9 years; thyrotropin [TSH]: mean +/- SEM, 42 +/- 6.5 mlU/L; r ange, 20.5 to 106.5) and 14 patients with subclinical hypothyroidism ( 13 women and one man aged 41 +/- 4 years; TSH: mean +/- SEM, 9.1 +/- 1 mlU/L; range, 5.1 to 17.3), Easting serum lipid levels were measured initially and 4 months after achievement of a euthyroid state with inc remental L-thyroxine therapy (TSH: mean +/- SEM, 1.8 +/- 0.4 mlU/L: ra nge, 0.3 to 4.9 for both groups). In the overtly hypothyroid group, re storation of a euthyroid state was associated with a significant reduc tion in total cholesterol, and apo B. In the subclinically hypothyroid group, there was a significant reduction of only total cholesterol (1 99.6 +/- 13.2 v 183.4 +/- 11.6 mg/dL) and LDL-C (131.6 +/- 8.4 v 114 /- 9.25 mg/dL). In contrast, lipoprotein(a) [Lp(a)] was unaffected by the incremental adjustment of L-thyroxine therapy in both groups (over t, 34.3 +/- 8.8 v 35.6 +/- 6.7 mg/dL; subclinical, 23.0 +/- 8.6 v 29.4 +/- 9.5 mg/dL). We conclude that restoration of a euthyroid state in patients with overt hypothyroidism has no significant effect on Lp(a) levels, and confirm that subclinical hypothyroidism is associated with a significant increase in LDL C. known to have an atherogenic effect. Copyright (C) 1995 by W.B. Saunders Company